메뉴 건너뛰기
Cutis
Volumn 80, Issue 5 SUPPL., 2007, Pages 20-28
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: Add-on therapy in the COBRA trial
Author keywords

[No Author keywords available]
Indexed keywords

CLOBETASOL; GLUCOCORTICOID;
EID: 37049034051     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (23)
References (10)
  • 1
    • 84914709973 scopus 로고    scopus 로고
    • Topical therapies for localized psoriasis
    • Witman PM. Topical therapies for localized psoriasis. Mayo Ctin Proc. 2001;76:943-949.
    • (2001) Mayo Ctin Proc , vol.76 , pp. 943-949
    • Witman, P.M.1
  • 2
    • 1542344331 scopus 로고    scopus 로고
    • Combination therapy to treat moderate to severe psoriasis
    • Lebwohl M, Menter A, Koo J, et al. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-430.
    • (2004) J Am Acad Dermatol , vol.50 , pp. 416-430
    • Lebwohl, M.1    Menter, A.2    Koo, J.3
  • 3
    • 33645545779 scopus 로고    scopus 로고
    • Psoriasis treatment in the United States at the end of the 20th century
    • Pearce DJ, Stealey KH, Balkrishnan R, et al. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006;45:370-374.
    • (2006) Int J Dermatol , vol.45 , pp. 370-374
    • Pearce, D.J.1    Stealey, K.H.2    Balkrishnan, R.3
  • 4
    • 37049024301 scopus 로고    scopus 로고
    • Wolters Kluwer PHAST [database]. Yardley, Pa: Wolters Kluwer, Source® Pharmaceutical Audit Suite (PHAST); June 2007.
    • Wolters Kluwer PHAST [database]. Yardley, Pa: Wolters Kluwer, Source® Pharmaceutical Audit Suite (PHAST); June 2007.
  • 5
    • 37049023656 scopus 로고    scopus 로고
    • Clobex Spray, 0.05, package insert, Fort Worth, Tex: Galderma Laboratories, LP; 2005
    • Clobex Spray, 0.05% [package insert]. Fort Worth, Tex: Galderma Laboratories, LP; 2005.
  • 6
    • 33845655894 scopus 로고    scopus 로고
    • Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis
    • Jarratt MT, Clark SD, Savin RC, et al. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. Cutis. 2006;78:348-354.
    • (2006) Cutis , vol.78 , pp. 348-354
    • Jarratt, M.T.1    Clark, S.D.2    Savin, R.C.3
  • 7
    • 33748911090 scopus 로고    scopus 로고
    • An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis
    • Beutner K, Chakrabarty A, Lemke S, et al. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol. 2006;5:357-360.
    • (2006) J Drugs Dermatol , vol.5 , pp. 357-360
    • Beutner, K.1    Chakrabarty, A.2    Lemke, S.3
  • 8
    • 37049026657 scopus 로고    scopus 로고
    • Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial
    • Menter A. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial. Cutis. 2007;80(suppl 5):12-19.
    • (2007) Cutis , vol.80 , Issue.SUPPL. 5 , pp. 12-19
    • Menter, A.1
  • 9
    • 0028332995 scopus 로고
    • Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use
    • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994:19:210-216.
    • (1994) Clin Exp Dermatol , vol.19 , pp. 210-216
    • Finlay, A.Y.1    Khan, G.K.2
  • 10
    • 20444466784 scopus 로고    scopus 로고
    • Decision points for the initiation of systemic treatment for psoriasis
    • Feldman SR, Koo JY, Menter A, et al. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53:101-107.
    • (2005) J Am Acad Dermatol , vol.53 , pp. 101-107
    • Feldman, S.R.1    Koo, J.Y.2    Menter, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.